Published

Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Pharmaceutica Acta Helvetiae
Date: 1997-06-01
Source: Crossref
DOI: 10.1016/s0031-6865(97)00014-9
PubMed: 9204776

Authors

Hasler F.Bourquin D.Brenneisen R.Bär T.Vollenweider F.X.

Watch author

Derived topics and classifications

psilocybin psilocin Pharmacology Other

Citation graph

21 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

10.1016/s0021-9673(00)88741-5 10.1016/s0021-9673(01)81831-8 10.1016/s0021-9673(00)92956-x 10.1016/s0021-9673(01)96375-7 10.1055/s-2007-1000662 10.1016/0006-2952(61)90124-1 10.1016/0041-008x(62)90102-3 10.1016/0006-2952(62)90050-3 10.1016/s0021-9673(01)90521-7 10.1016/s0021-9673(00)94447-9 10.1016/s0021-9673(00)94264-x 10.1016/s0378-4347(00)82279-3

Indexed papers citing this DOI

DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in Zebrafish2026-06-18 Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake2026-05-23 The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratus2026-05-07 Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain Exposure2026-02-12 Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress2026-01-02 Cross-Species Evidence for Psilocin-Induced Visual Distortions: Apparent Motion Is Perceived by Both Humans and Rats2025-09-01 Effects of Psilocin and Psilocybin on Human 5-HT4 Serotonin and H2 Histamine Receptors in Perfused Hearts of Transgenic Mice2025-07-06 Efficient Acyloxymethylation of Psilocin and Other Tryptamines Yielding ACOM Prodrugs for Psychedelic-Assisted Therapy2025-07-01 Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans2025-04-21 Elucidating the Phase I metabolism of psilocin in vitro2025-03-01 Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis2025-01-01 Effects of psilocin and psilocybin on human 5-HT4 serotonin receptors in atrial preparations of transgenic mice and humans2024-07-01 In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin2024-04-29 In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin2024-01-08 Development and validation of a sensitive LC-MS-MS method to quantify psilocin in authentic oral fluid samples2023-12-12 Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models2023-09-01 Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience2021-09-01 Sensitive quantitative analysis of psilocin and psilocybin in hair samples from suspected users and their distribution in seized hallucinogenic mushrooms2021-07-01 Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans2021-03-15 Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma2021-02-01